Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 4/20 | 0.61 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | CA1 | P00915 | 2/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | CA4 | P22748 | 2/20 | 0.53 |
| ▸ | CA7 | P43166 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | CA6 | P23280 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7372011 | 0.85 | POLB (0.48) | POLBCA12CA1CA2CA4 | |
| SCHEMBL14744092 | 0.83 | POLB (0.41) | POLBCA12CA1CA2CA4 | |
| SCHEMBL28780147 | 0.83 | AKR1C3 (0.50) | POLBALDH1A1RAB9AKDM4ETDP1 | |
| SCHEMBL10869194 | 0.82 | SIRT1 (0.55) | POLBALDH1A1RAB9AKDM4EHPGD | |
| SCHEMBL5960318 | 0.82 | ALDH1A1 (0.44) | POLBCA12CA1CA2CA4 | |
| SCHEMBL11093857 | 0.79 | LMNA (0.65) | POLBCA1CA2CA9ALDH1A1 | |
| SCHEMBL11084593 | 0.78 | SLC6A2 (0.54) | POLBHPGDTDP1MAPTGAA | |
| SCHEMBL11440098 | 0.78 | POLB (0.42) | POLBALDH1A1HPGDSMN1; SMN2TDP1 | |
| SCHEMBL5330637 | 0.77 | POLB (0.68) | POLBCA12CA1CA2CA4 | |
| Hydrochloric Acid SCHEMBL11093147 | 0.77 | IDO1 (0.47) | POLBCA12CA1CA2CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117342991-A | Sustained-release high-alkaline cement reinforcing agent and preparation method and application thereof | 华新水泥股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-117342991-B | Sustained-release high-alkaline cement reinforcing agent and preparation method and application thereof | 华新建材集团股份有限公司 | 2026-02-03 | — | — | CN | disclosed |
| US-20250051763-A1 | METHODS AND SYSTEMS FOR CONDITIONALLY REGULATING GENE EXPRESSION | FUNDACAO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD FOUNDATION (PT) | 2025-02-13 | — | — | US | disclosed |
| CN-117342812-B | Preparation method of slow-release enhanced cement grinding aid | 华新水泥股份有限公司 | 2025-01-28 | — | — | CN | disclosed |
| US-20240084335-A1 | CHIMERIC PROTEINS AND METHODS OF REGULATING GENE EXPRESSION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2024-03-14 | — | — | US | disclosed |
| CN-117342812-A | Preparation method of slow-release enhanced cement grinding aid | 华新水泥股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| CN-117342991-A | Sustained-release high-alkaline cement reinforcing agent and preparation method and application thereof | 华新水泥股份有限公司 | 2024-01-05 | — | — | CN | disclosed |
| US-20230416336-A1 | CHIMERIC PROTEINS AND METHODS OF IMMUNOTHERAPY | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-12-28 | — | — | US | disclosed |
| US-11773411-B2 | Chimeric proteins and methods of regulating gene expression | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-10-03 | — | — | US | disclosed |
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | Quantum-Si Incorporated (US) | 2023-05-23 | — | — | US | disclosed |
| EP-0892813-A1 | RECOMBINANT PREPARATION OF CALCITONIN FRAGMENTS AND USE THEREOF IN THE PREPARATION OF CALCITONIN AND RELATED ANALOGS | BIONEBRASKA, INC. (US) | 1999-01-27 | — | — | EP | disclosed |
| EP-0796335-A1 | PRODUCTION OF PEPTIDES USING RECOMBINANT FUSION PROTEIN CONSTRUCTS | BIONEBRASKA, INC. (US) | 1997-09-24 | — | — | EP | disclosed |
| WO-1997029127-A1 | RECOMBINANT PREPARATION OF CALCITONIN FRAGMENTS AND USE THEREOF IN THE PREPARATION OF CALCITONIN AND RELATED ANALOGS | BIONEBRASKA, INC. (US) | 1997-08-14 | — | — | WO | disclosed |
| WO-1996017942-A9 | PRODUCTION OF PEPTIDES USING RECOMBINANT FUSION PROTEIN CONSTRUCTS | — | 1996-08-15 | — | — | WO | disclosed |
| WO-1996017942-A1 | PRODUCTION OF PEPTIDES USING RECOMBINANT FUSION PROTEIN CONSTRUCTS | BIONEBRASKA, INC. (US) | 1996-06-13 | — | — | WO | disclosed |
| WO-1996017941-A2 | PRODUCTION OF C-TERMINAL AMIDATED PEPTIDES FROM RECOMBINANT PROTEIN CONSTRUCTS | BIONEBRASKA, INC. (US) | 1996-06-13 | — | — | WO | disclosed |
| CN-1019667-B | Process for preparing benzothiazinone derivatives | SHELL INT RESEARCH (NL) | 1992-12-30 | — | — | CN | disclosed |
| US-4833137-A | FUNGICIDES FOR PLANTS | SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) | 1989-05-23 | — | — | US | disclosed |
| CN-87104156-A | Benzo buprofezin derivate | — | 1987-12-16 | — | — | CN | disclosed |
| EP-0245902-A2 | Benzothiazinone derivatives | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1987-11-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | NSUN2, FBL, DNMT3A | POLB 79/4885CA12 2287/4885CA1 3619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.